ascendis pharma glp-1 Ozempic maker Novo Nordisk is working on a once-monthly weight-loss drug ascendis pharma glp-1 receptor agonist

The slower food movement through your gut can be one reason bloating occurs

Neurotransmitter Neurotransmitter: Gain insights into your brain chemistry and mood balance with our Neurotransmitter panel

However, results vary from person to person, and they are not guaranteed

This BCAC increases the activation of cytoplasmic phospholipase A2 (cPLA2) by binding to integrin 21 in platelets and promoting platelet hyperresponsiveness, thus promoting thrombosis [239]

Obesity and non-alcoholic fatty liver disease (NAFLD) collectively influence bone metabolism through systemic factors such as chronic inflammation, insulin resistance, dyslipidemia, and alterations in adipose tissue function

So one of them in people with obesity and one in people with obesity and diabetes, and those data are now published in Nature Medicine